134 results
Page 2 of 7
6-K
EX-5.2
n30fc3wil9crz
21 Sep 22
Current report (foreign)
8:00am
424B5
0v07j9g
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
9wmxaca
19 Sep 22
BioLineRx Announces $15 Million Registered Direct Offering
8:08am
6-K
EX-99
fegcjf4k8c2rki96opl
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
3gwnonh 1m0uf
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-10.1
sif6a6pv2 tq3
3 Sep 21
Current report (foreign)
4:30pm
424B5
rxk zlwplwv
3 Sep 21
Prospectus supplement for primary offering
4:29pm
POS AM
21y8io igtg
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99.2
03r9mpj
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
rr3yy2t
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
206e 14zxi
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99.1
yzt8pqzlv8crv5w
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
g71bubcpnndfn6w
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
n0c6atdwv05hit0esdu
21 Jan 21
Prospectus supplement for primary offering
4:31pm
FWP
ztpa3
19 Jan 21
Free writing prospectus
9:46pm
FWP
hoy6tky7qw b9v
19 Jan 21
Free writing prospectus
5:01pm
424B5
bq1addo mz3irp
19 Jan 21
Prospectus supplement for primary offering
5:00pm